Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Current Opinion in Oncology|November 30, 2011
p53: exercise capacity and metabolismPing-Yuan Wang, Jie Zhuang, Paul M Hwang
Molecular & Cellular Oncology|May 12, 2020
Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial diseaseMasahiro Nishi, Ping-Yuan Wang, Paul M Hwang
Arteriosclerosis, Thrombosis, and Vascular Biology|September 30, 2021
Cardiotoxicity of Cancer Treatments: Focus on Anthracycline CardiomyopathyMasahiro Nishi, Ping-Yuan Wang, Paul M Hwang
Science (New York, N.Y.)|March 5, 2005
OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activationPing-Yuan Wang, Jian Weng, Richard G W Anderson
Current Opinion in Genetics & Development|March 23, 2016
TP53 mutation, mitochondria and cancerWilliam M Kamp, Ping-Yuan Wang, Paul M Hwang
Methods in Enzymology|May 28, 2014
Cell-based measurements of mitochondrial function in human subjectsJu-Gyeong Kang, Ping-yuan Wang, Paul M Hwang
The Journal of Biological Chemistry|January 1, 2008
The N terminus controls sterol binding while the C terminus regulates the scaffolding function of OSBPPing-Yuan Wang, Jian Weng, Sungsoo Lee, et al.
Trends in Endocrinology and Metabolism: TEM|June 13, 2025
Mitochondrial innate immune signaling in skeletal muscle adaptation to exerciseJin Ma, Annie Yujin Son, Youlim Son, et al.
The EMBO Journal|May 30, 2003
A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activityPing-Yuan Wang, Pingsheng Liu, Jian Weng, et al.
Pageof 4